Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines

Christopher S. Burgey, Kyle A. Robinson, Terry A. Lyle, Philip E.J. Sanderson, S. Dale Lewis, Bobby J. Lucas, Julie A. Krueger, Rominder Singh, Cynthia Miller-Stein, Rebecca B. White, Bradley Wong, Elizabeth A. Lyle, Peter D. Williams, Craig A. Coburn, Bruce D. Dorsey, James C. Barrow, Maria T. Stranieri, Marie A. Holahan, Gary R. Sitko, Jacquelynn J. CookDaniel R. McMasters, Colleen M. McDonough, William M. Sanders, Audrey A. Wallace, Franklin C. Clayton, Dennis Bohn, Yvonne M. Leonard, Theodore J. Detwiler, Joseph J. Lynch, Youwei Yan, Zhongguo Chen, Lawrence Kuo, Stephen J. Gardell, Jules A. Shafer, Joseph P. VaccaShow 15 othersShow less